Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

After receiving a diagnosis of terminal cancer, he used his experience in public relations to draw attention to the skyrocketing cost of medication. By Clay Risen David Mitchell, a public relations ...